TAS0612

Delivery:: oral

MOA:: Small molecule triple kinase inhibitor of RSK1,2,3,4, AKT1,2,3 and S6K1,2

Indication:: Solid Tumours

S6K, AKT, RSK inhibitor

Phase 1 Study